|
27
|
114
|
3uyoA |
Crystal structure of monobody sh13/abl1 sh2 domain complex |
|
85
|
297
|
3vgoA |
Crystal structure of the n-terminal fragment of cbl-b |
|
39
|
160
|
3uf4A |
Crystal structure of a sh3 and sh2 domains of fyn protein (proto-concogene tyrosine-protein kinase fyn) from mus musculus at 1.98 a resolution |
|
25
|
99
|
3tl0A |
Structure of shp2 n-sh2 domain in complex with rlnpyaqlwhr peptide |
|
23
|
100
|
3tkzA |
Structure of the shp-2 n-sh2 domain in a 1:2 complex with rvipyfvplnr peptide |
|
31
|
98
|
3t04A |
Crystal structure of monobody 7c12/abl1 sh2 domain complex |
|
22
|
101
|
3s8lA |
Protein-ligand interactions: thermodynamic effects associated with increasing hydrophobic surface area |
|
27
|
105
|
1nrvA |
Crystal structure of the sh2 domain of grb10 |
|
24
|
103
|
5kazA |
Human sh2d1b structure |
|
122
|
389
|
5j3xA |
Structure of c-cbl y371f |
|
160
|
522
|
5ibsA |
Structure of e76q, a cancer-associated mutation of the oncogenic phosphatase shp2 |
|
106
|
302
|
5hkwA |
Crystal structure of apo c-cbl tkbd refined to 2.25 a resolution |
|
103
|
303
|
5hkzA |
Crystal structure of c-cbl tkbd in complex with spry2 peptide (36-60, py55) refined to 1.8 a resolution (p21 form) |
|
106
|
305
|
5axiA |
Crystal structure of cbl-b tkb domain in complex with cblin |
|
24
|
97
|
5gjhA |
Gads sh2 domain/cd28-derived peptide complex |
|
28
|
107
|
5gjiA |
Pi3k p85 n-terminal sh2 domain/cd28-derived peptide complex |
|
33
|
109
|
5aulA |
Pi3k p85 c-terminal sh2 domain/cd28-derived peptide complex |
|
27
|
103
|
5eeqA |
Grb7 sh2 with the g7-b1 bicyclic peptide inhibitor |
|
163
|
523
|
5ehpA |
Non-receptor protein tyrosine phosphatase shp2 in complex with allosteric inhibitor shp836 |
|
26
|
104
|
5eelA |
Grb7 sh2 with bicyclic peptide inhibitor |
|
26
|
113
|
5eg3B |
Crystal structure of the activated fgf receptor 2 (fgfr2) kinase domain in complex with the csh2 domain of phospholipase c gamma (plcgamma) |
|
156
|
522
|
5ehrA |
Non-receptor protein tyrosine phosphatase shp2 in complex with allosteric inhibitor shp099 |
|
23
|
98
|
5dc0B |
Crystal structure of monobody gg3/abl1 sh2 domain complex |
|
28
|
100
|
5dc4A |
Crystal structure of monobody as25/abl1 sh2 domain complex, crystal a |
|
27
|
100
|
5dc9A |
Crystal structure of monobody as25/abl1 sh2 domain complex, crystal b |
|
56
|
217
|
5df6A |
Crystal structure of ptpn11 tandem sh2 domains in complex with a txnip peptide |
|
23
|
106
|
5d0jA |
Grb7 sh2 with inhibitor peptide |
|
63
|
254
|
4xz1A |
Zap-70-tsh2:compound-b adduct |
|
70
|
258
|
4xz0A |
Zap-70-tsh2:compound-a complex |
|
29
|
112
|
4wwqA |
Apo structure of the grb7 sh2 domain |
|
25
|
106
|
4x6sA |
Grb7 sh2 domain with phosphotyrosine mimetic inhibitor peptide |
|
26
|
113
|
4u1pA |
Human fyn-sh2 domain in complex with a synthetic high-affinity phospho-peptide |
|
26
|
110
|
4tziA |
Structure of unliganded lyn sh2 domain |
|
26
|
103
|
4rojA |
Crystal structure of the vav2 sh2 domain in complex with txnip phosphorylated peptide |
|
21
|
102
|
4u17A |
Swapped dimer of the human fyn-sh2 domain |
|
25
|
100
|
4qsyA |
Shp2 sh2 domain in complex with gab1 peptide |
|
25
|
109
|
4p9zA |
Grb2 sh2 complexed with a ptyr-ac6c-asn tripeptide |
|
21
|
100
|
4p9vA |
Grb2 sh2 complexed with a ptyr-ac6cn-asn tripeptide |
|
154
|
526
|
4oheA |
Leopard syndrome-associated shp2/g464a mutant |
|
150
|
526
|
4ohhA |
Leopard syndrome-associated shp2/q506p mutant |
|
158
|
526
|
4ohiA |
Leopard syndrome-associated shp2/q510e mutant |
|
144
|
524
|
4ohlA |
Leopard syndrome-associated shp2/t468m mutant |
|
158
|
531
|
4nwfA |
Crystal structure of the tyrosine phosphatase shp-2 with n308d mutation |
|
155
|
533
|
4nwgA |
Crystal structure of the tyrosine phosphatase shp-2 with e139d mutation |
|
145
|
526
|
4ohdA |
Leopard syndrome-associated shp2/a461t mutant |
|
106
|
447
|
4ludA |
Crystal structure of hck in complex with the fluorescent compound skf86002 |
|
36
|
158
|
4m4zA |
Sh3 and sh2 domains of human src-like adaptor protein 2 (slap2) |
|
112
|
446
|
4lueA |
Crystal structure of hck in complex with 7-[trans-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7h-pyrrolo[2,3-d]pyrimidin-4-amine (resulting from displacement of skf86002) |
|
24
|
104
|
4k44A |
Auto-inhibition and phosphorylation-induced activation of plc-gamma isozymes |
|
129
|
448
|
4k11A |
The structure of 1na in complex with src t338g |
